Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Neural Regulation01:37

Neural Regulation

43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Brainstem01:19

Brainstem

6.9K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
6.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

1.8K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time AI integration for MR to detect artifacts and guide pulse sequence adaptations.

bioRxiv : the preprint server for biology·2026
Same author

Identifying Out-of-Voxel Echoes in Edited MRS With Phase Cycle Inversion.

Magnetic resonance in medicine·2025
Same author

Gradient scheme optimization for PRESS-localized edited MRS using weighted pathway suppression.

bioRxiv : the preprint server for biology·2025
Same author

Age dependency of neurometabolite T<sub>1</sub> relaxation times.

Magnetic resonance in medicine·2025
Same author

Metabolite T<sub>2</sub> relaxation times decrease across the adult lifespan in a large multi-site cohort.

Magnetic resonance in medicine·2024
Same author

A data-driven algorithm to determine <sup>1</sup>H-MRS basis set composition.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Feb 22, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.6K

Inhibitory motor dysfunction in parkinson's disease subtypes.

Tao Gong1, Yuanyuan Xiang2, Muhammad G Saleh3,4

  • 1Department of MR, Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong, P.R. China.

Journal of Magnetic Resonance Imaging : JMRI
|September 30, 2017
PubMed
Summary
This summary is machine-generated.

Lower GABA levels in the basal ganglia are observed in Parkinson's disease (PD) patients compared to controls. Differences in GABA levels exist between PD subtypes, suggesting GABAergic dysfunction in PD pathogenesis.

Keywords:
GABAMEGA-PRESSParkinson's diseasepostural instability gait difficultytremor

More Related Videos

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

56.4K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K

Related Experiment Videos

Last Updated: Feb 22, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.6K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

56.4K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medical Imaging

Background:

  • Parkinson's disease (PD) is characterized by motor subtypes: postural instability gait difficulty (PIGD) and tremor-dominant (TD).
  • The GABAergic system is increasingly implicated in the underlying mechanisms of PD.

Purpose of the Study:

  • To investigate and compare gamma-aminobutyric acid (GABA) levels between PIGD and TD subtypes of Parkinson's disease.
  • To utilize Magnetic Resonance Spectroscopy (MRS) for quantifying GABA concentrations in the basal ganglia.

Main Methods:

  • Magnetic Resonance Spectroscopy (MRS) with Mescher-Garwood Point Resolved Spectroscopy (MEGA-PRESS) was performed on 3.0T MRI scanners.
  • GABA+ (GABA plus macromolecules and homocarnosine) and Creatine (Cr) levels were quantified in the left basal ganglia (BG) of PD patients (PIGD n=13, TD n=9) and 16 healthy controls.
  • Analysis of Covariance (ANCOVA) was used to compare GABA+ levels between groups, and correlations with the Unified Parkinson's Disease Rating Scale (UPDRS) were assessed.

Main Results:

  • GABA+ levels were significantly lower in the left basal ganglia of PD patients compared to healthy controls (P < 0.001).
  • The tremor-dominant (TD) subtype exhibited lower GABA concentration than the postural instability gait difficulty (PIGD) subtype (P = 0.019).
  • Creatine levels were reduced in both PIGD and TD groups compared to controls. A negative correlation between GABA levels and UPDRS scores was observed in the PIGD group (r = -0.572, P = 0.041).

Conclusions:

  • Reduced basal ganglia GABA levels in Parkinson's disease patients suggest a role for GABAergic dysfunction in PD.
  • Observed differences in GABA levels between PIGD and TD subtypes may indicate distinct pathophysiological mechanisms.
  • These findings highlight the potential involvement of the GABAergic system in the progression and manifestation of Parkinson's disease motor subtypes.